Tag Archives: Wisconsin Bio News

Read the full press release here In his RSC Chemical Biology review article, “Reactive oxygen species, proinflammatory and immunosuppressive mediators induced in COVID-19: Overlapping biology with cancer,” Balaraman Kalyanaraman, PhD, professor and chair of biophysics and the Harry R. & Angeline E. Quadracci Professor in Parkinson’s Research, analyzes published literature linking the different mechanisms focused on oxidative […]

Read the full press release here FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced that it has been awarded funding from the United States Department of Defense to conduct a safety and immunogenicity study of M2SR, the Company’s investigational, supra-seasonal, live, single-replication, intranasal influenza (flu) vaccine. This study […]

Read the full press release here Seven projects – from generating valuable products from the abundant non-food dairy residues that remain after milk is processed into food product, to amplifying UW–Madison doctoral trainees as the new generation of biotechnology industry leaders – have been chosen for funding through the Promoting Industry Collaboration Initiative. These projects […]

Read the full press release here SHINE Medical Technologies LLC today announced that it has closed a $150-million Series C-5 financing. Koch Disruptive Technologies (KDT) led the round, which also included participation by Fidelity Management & Research Company, Baillie Gifford and other new and current investors. The financing will support SHINE’s commercialization of its diagnostic […]

Read the full press release here The Advancing a Healthier Wisconsin Endowment (AHW), a statewide philanthropy based at the Medical College of Wisconsin (MCW), has announced the award of $6.5 million to 17 projects aimed at improving health and advancing health equity across Wisconsin. “At the Advancing a Healthier Wisconsin Endowment, we are working to create […]

Read the full press release here The Medical College of Wisconsin (MCW) School of Pharmacy partnered with Nexus Pharmaceuticals, Inc. for a pharmaceutical clinical-use study to compare the use of EMERPHED™, a ready-to-use (RTU) ephedrine sulfate product, to the commercially-used concentrated ephedrine sulfate in a simulated operating room setting using MCW’s Standardized Teaching Assessment Resources (STAR) […]

Read the full press release here Promega Corporation is setting its most ambitious sustainability targets in the biotechnology manufacturer’s more than 40-year history. The 2021 Corporate Responsibility Report, released today, features new 2030 Environmental Improvement Goals alongside stories of how Promega is supporting researchers, employees and communities during the COVID-19 pandemic. Promega 2030 Environmental Improvement Goals […]

Read the full press release here Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has reached an agreement to acquire RheinCell Therapeutics GmbH, a developer and manufacturer of GMP-grade human induced pluripotent stem cells (iPSCs). […]

Read the full press release here Researchers at the Medical College of Wisconsin (MCW) have identified a linkage between contemporary ‘redlining’ (mortgage lending bias based on property location) and mortality after breast cancer diagnosis among older women in the United States. The results, published in the Journal of Clinical Oncology this week, show women residing […]